鎮痛薬の市場規模、シェア、成長分析、薬物タイプ別、投与経路別、用途別、流通チャネル別、地域別- 産業予測、2024～2031年

鎮痛薬の世界市場規模は2022年に386億米ドルと評価され、2023年の409億2,000万米ドルから2031年には652億1,000万米ドルに成長し、予測期間（2024～2031年）のCAGRは6.0％で成長する見通しです。

世界の鎮痛薬市場は、慢性疼痛の発生率の上昇、高齢者層の拡大、疼痛管理戦略をめぐる意識の高まりといった主要な洞察に後押しされ、一貫した成長を遂げています。このため、痛みや不快感を和らげるのに不可欠な鎮痛薬は、処方薬と市販薬の両方で需要が増加しています。ドラッグデリバリーシステムの革新、新規鎮痛製剤の上市、ジェネリック医薬品の供給の増加が、市場の拡大を刺激し続けています。さらに、業界をリードする企業間の戦略的提携、合併、買収は、製品ポートフォリオを強化し、鎮痛薬分野での世界的プレゼンスを拡大することを目的としています。全体として、これらの要因が、今後数年間の鎮痛薬市場の堅調な見通しを支えています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• 特許分析
• ケーススタディ
• スタートアップ分析

鎮痛薬の市場規模：薬の種類別& CAGR（2024-2031）

• 市場概要
• オピオイド鎮痛薬
  • モルヒネ
  • フェンタニル
  • オキシコドン
  • ヒドロコドン
• 非オピオイド鎮痛薬
  • 非ステロイド性抗炎症薬（NSAIDs）
  • イブプロフェン
  • ナプロキセン
  • アスピリン
  • アセトアミノフェン
  • 複合鎮痛薬

鎮痛薬の市場規模：投与経路別& CAGR（2024-2031）

• 市場概要
• 経口
  • 錠剤
  • カプセル
  • 液体
• 局所的
  • クリーム
  • ジェル
  • パッチ
• 注射
  • 静脈内
  • 筋肉内
• 経皮

鎮痛薬の市場規模：用途別& CAGR（2024-2031）

• 市場概要
• 慢性疼痛
  • 関節炎
  • がんの痛み
  • 神経障害性疼痛
• 急性疼痛
  • 術後の痛み
  • 怪我の痛み
• その他
  • 片頭痛
  • 線維筋痛症

鎮痛薬の市場規模：流通チャネル別& CAGR（2024-2031）

• 市場概要
• 病院薬局
• 小売薬局
• オンライン薬局

鎮痛薬の市場規模：地域別& CAGR（2024-2031）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021-2023）

主要企業プロファイル

• Pfizer Inc.
• Johnson & Johnson
• GlaxoSmithKline plc（GSK）
• Sanofi S.A.
• Bayer AG
• Novartis AG
• Merck & Co., Inc.
• AstraZeneca PLC
• Bristol-Myers Squibb Company
• AbbVie Inc.
• Eli Lilly and Company
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Endo Pharmaceuticals Inc.
• Purdue Pharma L.P.
• Mallinckrodt Pharmaceuticals
• Horizon Therapeutics plc
• Sun Pharmaceutical Industries Ltd.
• Dr. Reddy's Laboratories Ltd.
• Zydus Cadila

結論と推奨事項

Global Analgesics Market size was valued at USD 38.6 billion in 2022 and is poised to grow from USD 40.92 billion in 2023 to USD 65.21 billion by 2031, growing at a CAGR of 6.0% during the forecast period (2024-2031).

The global analgesics market is experiencing consistent growth, propelled by key insights such as the rising incidence of chronic pain, an expanding elderly demographic, and heightened awareness surrounding pain management strategies. This has led to increased demand for both prescription and over-the-counter analgesic drugs, essential for alleviating pain and discomfort. Innovations in drug delivery systems, the launch of novel analgesic formulations, and a rising availability of generic alternatives continue to stimulate market expansion. Furthermore, strategic partnerships, mergers, and acquisitions among leading industry players are aimed at enhancing product portfolios and broadening their global presence in the analgesics sector. Overall, these factors collectively underpin the robust outlook for the analgesics market in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Analgesics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Analgesics Market Segmental Analysis

Global Analgesics Market is segmented by drug type, route of administration, application, distribution channel and region. Based on drug type, the market is segmented into opioid analgesics and non-opioid analgesics. Based on route of administration, the market is segmented into oral, topical, injectable and transdermal. Based on application, the market is segmented into chronic pain, acute pain and other. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Analgesics Market

One of the key factors propelling the global analgesics market is the rising incidence of chronic pain conditions among the population. A considerable number of individuals experience chronic pain from ailments such as arthritis, cancer, neuropathic pain, and musculoskeletal disorders, which escalates the demand for effective pain management solutions. This persistent need for relief demands innovative analgesic drugs that enhance patients' quality of life. Furthermore, increasing awareness surrounding pain management techniques and ongoing advancements in pharmaceutical research contribute to the development of new and improved analgesics, playing a significant role in driving market expansion and catering to the growing needs of pain sufferers globally.

Restraints in the Global Analgesics Market

A significant challenge facing the global analgesics market is the inherent risk of side effects and the potential for abuse associated with certain analgesic medications. Opioid analgesics are particularly problematic due to their association with dependence, addiction, and the risk of overdose, contributing to widespread public health issues. Consequently, there has been growing regulatory scrutiny, resulting in the implementation of stricter prescribing guidelines for these medications. Healthcare providers are exercising increased caution in prescribing and monitoring opioids, which has prompted a shift toward non-opioid alternatives and other pain management strategies. This balancing act between providing effective pain relief and mitigating abuse risks hampers the market's overall growth.

Market Trends of the Global Analgesics Market

A significant trend in the global analgesics market is the escalating demand for non-opioid analgesics, driven by increasing awareness about the risks associated with opioid use, including addiction and overdose. This shift is prompting healthcare professionals and consumers alike to seek safer alternatives for pain management. Non-opioid options, such as nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen, are emerging as preferred choices for treating mild to moderate pain, thereby reshaping the market landscape. As a result, pharmaceutical companies are investing in innovative formulations and research aimed at enhancing the efficacy and safety profiles of non-opioid analgesics to meet this evolving demand.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Patent Analysis
• Case Studies
• Startup Analysis

Global Analgesics Market Size by Drug Type & CAGR (2024-2031)

• Market Overview
• Opioid Analgesics
  • Morphine
  • Fentanyl
  • Oxycodone
  • Hydrocodone
• Non-Opioid Analgesics
  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
  • Ibuprofen
  • Naproxen
  • Aspirin
  • Acetaminophen
  • Compound Analgesics

Global Analgesics Market Size by Route Of Administration & CAGR (2024-2031)

• Market Overview
• Oral
  • Tablets
  • Capsules
  • Liquids
• Topical
  • Creams
  • Gels
  • Patches
• Injectable
  • Intravenous
  • Intramuscular
• Transdermal

Global Analgesics Market Size by Application & CAGR (2024-2031)

• Market Overview
• Chronic Pain
  • Arthritis
  • Cancer Pain
  • Neuropathic Pain
• Acute Pain
  • Postoperative Pain
  • Injury Pain
• Other
  • Migraine
  • Fibromyalgia

Global Analgesics Market Size by Distribution Channel & CAGR (2024-2031)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Analgesics Market Size & CAGR (2024-2031)

• North America (Drug Type, Route Of Administration, Application, Distribution Channel)
  • USA
  • Canada
• Europe (Drug Type, Route Of Administration, Application, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Drug Type, Route Of Administration, Application, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Drug Type, Route Of Administration, Application, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Drug Type, Route Of Administration, Application, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (GSK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol-Myers Squibb Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endo Pharmaceuticals Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Purdue Pharma L.P.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mallinckrodt Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horizon Therapeutics plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Cadila
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations